01.08.26 -- The 2020 Pediatric Mandate That Shook Up Oncology Research

A panel of experts from across the pharmaceutical/biopharmaceutical industry shared their experiences in mitigating financial risk before partnering with a CRO.

Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims. Demand better technology, pricing transparency, and dedicated partnership.

The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.

An RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.

Stability testing is essential to ensuring your drug’s stability, potency, efficacy, and safety under different controlled conditions throughout development, manufacturing, and life cycle management.

The rapidly evolving landscape of oncology clinical trials, driven by innovative technologies and deeper insights into cancer biology, presents unique challenges and opportunities for U.S. biotech companies.

Drive your program forward with an experienced partner ready to execute early-phase clinical research with exceptional speed and scientific rigor.

See how a cutting-edge, multi-purpose isolator line delivers high-speed, precision fill/finish. This flexible technology supports a diverse range injectable therapies.

Learn how a bioanalytical testing partner with comprehensive solutions and unwavering commitment to quality can help you bring safe and effective drugs to market with confidence.

MHRA’s IRP accelerates UK approvals via trusted regulators, but faster authorization only translates to access when aligned with NICE evidence needs, pricing policy, and coordinated launch strategy.

Failing to comply with disclosure rules can leave sponsors open to fines and penalties. We present the latest disclosure requirements, enforcement mechanisms, and tips on how best to stay compliant.

By prioritizing adaptive trial designs and strategic logistical planning, developers can overcome significant barriers to accelerate the delivery of transformative treatments to patients.

Find customized, end-to-end clinical and regulatory solutions, guiding biotechnology, pharmaceutical, and medical device companies through the entire product lifecycle.